AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04198779 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: APPLI
Description: The support with the digital application is including a 10-minutes training about the use of the digital application at the beginning of the study. Patient will have to register information about their Heart failure disease (weight, shortness of breath, fatigue, mood, cardiologist appointments, blood results, ...). During each routine consultation, patients will be encouraged to use the digital app, and the obstacles encountered will be explored and resolved. In addition, participants will receive an email containing relevant information and, every three months, an email reminder of the use of the application.
Study NCT03141502 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Skin stretching device (SSD)
Description: By making use of skin viscoelasticity, the special metal crochet of SSD would be embedded in both sides skin of the wound. Multiple cycles of stretching and relaxing wound lead to extended skin, changing the high tension incision into a low tension incision and facilitating the direct suture.
Study NCT03141502 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Skin grafting
Description: the standard technique of skin grafting after wound preparation.
Study NCT00738842 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD6140
Description: Oral tablets taken bid for 5 days
Study NCT00738842 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to match AZD6140
Description: Oral tablets taken bid for 5 days
Study NCT03219944 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Platelet Rich Fibrin
Description: : Platelet Rich Fibrin for soft tissue augmentation around implant in the aesthetic zone
Study NCT03219944 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: sub epithelial connective tissue graft
Description: sub epithelial connective tissue graft for soft tissue augmentation around implant in the aesthetic zone
Study NCT02669329 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CoolSculpting device with vacuum applicator.
Description: The CoolSculpting device with a vacuum applicator will be used to perform the treatments.
Study NCT03818373 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: polysomnography
Description: Sleep examination strictly non-invasive with skin sensors. This exploration would allow for the detection of respiratory sleep disorders and consider of appropriate management for patients.
Study NCT05549102 — intervention group
Intervention type: BEHAVIORAL
Intervention: Cognitive Behavioural Therapy
Description: In the Cognitive Behavioural Therapy group (N=87), patients will undergo CBT as part of their routine care in Step 3 of the IAPT programme. This will be administered by suitably trained clinicians. The specification of CBT is as recommended by the National Institute for Health and Care Excellence (NICE) guidelines (CG113 - Generalised anxiety disorder and panic disorder in adults: management). In these guidelines, patients are offered on average, 12-15 hourly, weekly sessions of CBT with a trained and competent practitioners. Therapy sessions involve discussions that identify patterns in thinking or behaviours which may be problematic, and therapists and patients work to set goals to reduce these using cognitive techniques. The principle is to teach the patient how to use CBT techniques in their day-to-day life to promote a lasting effect on mental health. We will test patients before (T1) and after (T2) a course of treatment.
Study NCT05549102 — intervention group
Intervention type: OTHER
Intervention: Waiting List
Description: In the control group (N=87), we will test patients who are currently seeking (but not undergoing) treatment before (T1) and after a wait (T2) of equivalent time (i.e. waiting list controls)
Study NCT02038114 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Instructed to read patient education pamphlets
Description: The intervention in this study is the administration of patient education pamphlets and instructions to read them. Half of all patients who participate in this study will be required to read pamphlets on symptoms that are relevant to them (i.e. symptoms that they are experiencing). Subsequent to reading pamphlets, patients will complete study questionnaires to assess their impact.
Study NCT03322449 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Animal Diet
Description: during one week participants will receive food products enriched in animal products and with high content of fat and protein
Study NCT01683552 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Prednisone
Description: In the refractory group (VAS score ≥7), Aprepitant (125 mg on day 1; 80 mg on day 3; 80 mg on day 5) is administered after at least one week of standard systemic treatment (prednisone 25 mg/die and/or fexofenadine 180 mg/die),
Study NCT01683552 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Fexofenadine
Description: In the refractory group (VAS score ≥7), Aprepitant (125 mg on day 1; 80 mg on day 3; 80 mg on day 5) is administered after at least one week of standard systemic treatment (prednisone 25 mg/die and/or fexofenadine 180 mg/die)
Study NCT03020836 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Referral to primary care physician for hypertension control
Description: Referral to primary care physician for hypertension control
Study NCT03020836 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Referral to smoking quit line
Description: Referral to Maryland Tobacco/Smoking quit line for help with smoking cessation
Study NCT01303588 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Yoga
Description: 24 group training sessions Yoga, 2 training sessions per week, 45 min duration , over 3 months
Study NCT01303588 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Qigong
Description: 12 group training sessions Qigong, 1 training per week, 90 min duration , over 3 months
Study NCT02576054 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: V501
Description: Quadrivalent HPV \[Type 6, 11, 16 and 18\] L1 VLP vaccine), 0.5 mL intramuscular injection on Day 1, Month 2, and Month 6
Study NCT00751998 — intervention group
Intervention type: DEVICE
Intervention: SpyGlass
Description: The SpyGlass Direct Visualization System is an integrated product platform that is designed to provide a direct intraluminal view of the biliary duct system and direct therapeutic devices.
Study NCT03292965 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neostigmine
Description: Referring to the randomisation allocation program, participants allocated to group neostigmine, administrate neostigmine as reversal
Study NCT03292965 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sugammadex
Description: Referring to the randomisation allocation program, participants allocated to group sugammadex, administrate sugammadex as reversal
Study NCT01543815 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Well-Being Therapy based on Web Mobile Technology
Description: The techniques included in WBT may be used in overcoming impairments in environmental mastery, purpose in life, personal growth, autonomy, self-acceptance and positive relations with others.
Study NCT01543815 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Behavior Therapy
Description: CBT involves several essential features: identifying and correcting inaccurate thoughts associated with depressed feelings (cognitive restructuring); helping patients to engage more often in enjoyable activities (behavioral activation); enhancing problem-solving skills; providing instruction and guidance in specific strategies for solving problems.
Study NCT01543815 — intervention group
Intervention type: OTHER
Group type: NO_INTERVENTION
Intervention: Standardized Care Management
Description: CM will consist of reviewing the patients' clinical status, and providing the patient with support and advice if necessary.
Study NCT04315389 — intervention group
Intervention type: DEVICE
Intervention: (1) Mobile Assistant Balance Robot
Description: MRBA: Robotic wheelchair with a planar compliant robotic arm to provide balance assistance to the user at the pelvis and hip, during sit to stand, standing and walking tasks in indoor and controlled outdoor level environments.
Study NCT04315389 — intervention group
Intervention type: DEVICE
Intervention: (2) Transfer Assistive Cobot
Description: TAC: Intelligent powered wheelchair equipped with a robotic arm that is capable of lifting payload up to 110kg, and perform a totally dependent transfer in a semi- autonomous fashion
Study NCT03196648 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gingival health formulation in an accelerating device
Description: The intervention is a gingival health formulation for soft tissue maintenance, oral malodor and gentle teeth whitening to be used with the GLO Science Device
Study NCT03196648 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gingival health formulation on a toothbrush
Description: The intervention is a gingival health formulation for soft tissue maintenance, oral malodor and gentle teeth whitening to be used on a toothbrush together with toothpaste.
Study NCT03196648 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: OTC fluoride toothpaste
Description: OTC anti-cavity toothpaste containing fluoride and sodium monofluorophosphate.
Study NCT03196648 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: OTC fluoride toothpaste
Description: OTC anti-cavity toothpaste containing fluoride and sodium monofluorophosphate.
Study NCT02808962 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Cooled RFA of sacral lateral branches
Description: A single target will be identified at the junction of the sacral ala and S1 superior articular process, corresponding to the location of the L5 dorsal ramus. Then, utilizing a stainless steel Epsilon Ruler (Kimberly Clark, Irving, TX, USA), three targets will be localized 8-10 mm lateral to the S1 and S2 posterior sacral foramen at the 2:30, 4:00, and 5:30 positions. Two targets will be localized at the S3 level. Local infiltration with 1% lidocaine and minimal sedation with IV midazolam will be utilized. Once suitable sensory and motor stimulation are verified and impedance is acceptable, each target will be anesthetized with 1 mL of 1% lidocaine prior to each lesion being created at 60 degrees centigrade for 2 minutes and 30 seconds.
Study NCT03322449 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plant Diet
Description: during one week participants will receive plant products enriched in fiber and complex carbohydrates
Study NCT04097119 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Dietary supplementation
Description: Subjects receive a specific dietary supplementation designed to support HDL function daily for 12 weeks
Study NCT04427280 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Throat/nose swabs
Description: Throat/nose swabs will initially be collected at baseline (D0) as part of the diagnostic workup for SARS-CoV-2 infection. Subsequent throat/nose swabs will be taken at D7 (if an inpatient), D14, D28, D42 and D56. Two samples will be taken, one for standard of care testing and one for lateral flow assay and storage for further analysis later such as quantitative PCR.
Study NCT04427280 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Saliva collection
Description: Saliva will be collected at each study visit, by asking the participant to provide a small amount of saliva (approximately 0.5mL) will be collected. Saliva will be tested by the lateral flow assay when available and excess material stored.
Study NCT04427280 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood collection
Description: Approximately 30mL of blood will be taken at each study visit.
Study NCT03300388 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Omega-3 (DHA-rich dietary supplement)
Description: Double-blind randomized placebo-controlled intervention with DHA-rich dietary supplement with or without resistance training program for 16 weeks.
Study NCT03300388 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (olive oil)
Description: Double-blind randomized placebo-controlled intervention with DHA-rich dietary supplement with or without resistance training program for 16 weeks.
Study NCT06541418 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transtheoretic Model Based Behavior Change Program
Description: The Behavior Change Program was implemented in 7 sessions of 50 minutes, once a week. Each session in the Behavior Change Program; The warm-up exercise consisted of giving general information about the purpose and the main theme of the session, discussion and feedback on the subject, and the planning of the next week, and a closing process. The Transtheoretic Model Based Behavior Change Program was prepared by the researcher with reference to the behavior change programs in the literature and the elements of the Transtheoretic model.
Study NCT01630265 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard written discharge instructions
Description: Group of caregivers who read the standard written discharge instructions prior to answering the questionnaire
Study NCT01630265 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video Discharge Instructions
Description: Group of caregivers who watched the 3 minute video covering the information in the standard written discharge instructions prior to answering the questionnaire
Study NCT02055183 — intervention group
Intervention type: DRUG
Intervention: BAT
Description: Noninterventional, retrospective, observational phase 4 patient Registry
Study NCT02492295 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: Propofol will be administered as a 0.5mg/kg (at a concentration of 10mg/mL, rounded to the nearest 0.5mL) initial bolus, followed by repeat 0.25mg/kg boluses (same rounding) every three to five minutes as needed to maintain RASS target -2 (light sedation - awakens to voice \<10 seconds) to RASS target of -3 (moderate sedation - movement or eye opening without eye contact) for 15 minutes. No more than 1.5mg/kg of propofol will be administered over this time period. After the sedation session is complete, patients will be allowed to wake up and will be monitored in the ED for at least another hour prior to discharge.
Study NCT01207063 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Radiotherapy and concurrent chemo-therapy
Description: Radiotherapy and concurrent chemo-therapy
Study NCT02805582 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 10ml ropivacain 0.5%
Description: Ultrasound guided nerve block
Study NCT03300388 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo (olive oil)
Description: Double-blind randomized placebo-controlled intervention with DHA-rich dietary supplement with or without resistance training program for 16 weeks.
Study NCT03300388 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance training
Description: Double-blind randomized placebo-controlled intervention with DHA-rich dietary supplement with or without resistance training program for 16 weeks.
Study NCT02343341 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Preschool Health Promotion Education Program
Study NCT01083758 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: LEO 80185 (Taclonex® Scalp topical suspension/Xamiol® gel)
Description: Topical suspension applied once daily for up to 8 weeks
Study NCT02789124 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Carotid Doppler Measurement in response to passive leg raise
Description: The investigators will measure Carotid Flow time in the semi-recumbent position, then lay the patient flat and do a passive leg raise. The investigators will then meausre Carotid Flow Time at 1 minute, 2 minutes, and 3 minutes. Patients who have 10 % increase in stroke volume on the Flotrac / Vigileo monitor will be considered fluid responders. The investigators will try to identify an optimum % increase of Carotid Flow Time that can predict fluid responsiveness.
Study NCT00808210 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ocrelizumab
Description: Intravenous repeating dose
Study NCT00808210 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Intravenous repeating dose
Study NCT00808210 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Intravenous repeating dose
Study NCT04084067 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indocyanine Green
Description: IV
Study NCT00360282 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Rizatriptan
Description: 10 mg Rizatriptan in an unlabeled pill given once on one of two visits
Study NCT02343341 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Preschool Health Promotion Education Program
Study NCT03866993 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AK105
Description: IV infusion
Study NCT02097368 — intervention group
Intervention type: PROCEDURE
Intervention: tongue strength measurement
Description: tongue strength measurement
Study NCT02097368 — intervention group
Intervention type: PROCEDURE
Intervention: respiratory function measurement
Description: respiratory function measurement
Study NCT03866993 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: IV infusion
Study NCT03866993 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Paclitaxel
Description: IV infusion
Study NCT03866993 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: IV infusion
Study NCT03866993 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Carboplatin
Description: IV infusion
Study NCT03866993 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: IV infusion
Study NCT01773226 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Autologous Protein Solution APS(TM)
Description: A therapy prepared at the point-of-care from a small sample of the patient's own blood containing high concentrations of anti-inflammatory and anabolic proteins
Study NCT01429259 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: meropenem
Description: meropenem 40mg/kg total body weight will be administered every 8 hours. Each infusion will be infused as a 3 hour infusion.
Study NCT01323699 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy
Description: A modified version of existing Cognitive Behavioral Treatment and Self-management manuals.
Study NCT01895504 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ColoAssist
Description: Screening colonoscopy with the test instrument
Study NCT01895504 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MEI
Description: Colonoscopy with Olympus colonoscopes and MEI guidance
Study NCT03882125 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-based relapse prevention
Description: Psychosocial intervention integrating mindfulness practice and cognitive behavioral relapse prevention approaches
Study NCT01134874 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard weight loss intervention
Description: In-person weight loss sessions, dietary intake prescription of 1200-1500 kcal per day, exercise progressing to 300 minutes per week.
Study NCT01134874 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard weight loss intervention plus technology
Description: In-person weight loss sessions, dietary intake prescription of 1200-1500 kcal per day, exercise progressing to 300 minutes per week, plus technology to provide real-time feedback on energy expenditure, plus a website to log dietary intake.
Study NCT01134874 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Technology only
Description: One intervention telephone call per month, dietary intake prescription of 1200-1500 kcal per day, exercise progressing to 300 minutes per week, plus technology to provide real-time feedback on energy expenditure, plus a website to log dietary intake.
Study NCT02341716 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: WA
Description: Walk advice with Nordic Poles and best medical treatment
Study NCT02341716 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SET
Description: Walk advice with Nordic Poles, best medical treatment and hospital-based supervised exercise therapy
Study NCT02341716 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: HET
Description: Walk advice with Nordic Poles, best medical treatment and home-based supervised exercise therapy
Study NCT03778294 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo PET/CT
Study NCT03778294 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fluorodopa F 18
Description: Given IV
Study NCT03778294 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo PET/MRI
Study NCT03778294 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT or PET/MRI
Study NCT03778294 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Proton Beam Radiation Therapy
Description: Receive proton beam RT
Study NCT03778294 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT03778294 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT03778294 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Drug
Study NCT02152995 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo iodine I-124 PET/CT